Leveraging AI to automate clinical intelligence in biotech
DOWNLOAD E-BOOK
In the last 12 months, there were over 2.5 million changes in the U.S. clinical trials registry. That equates to nearly 6,800 updates per day. Many of these changes are expected, however, deviations from the path make it possible to identify patterns that can anticipate trial outcomes.
Pinpointing these outliers is central to how biotech upstarts, pharmaceutical companies, and investors stay ahead of the curve of the industry's news cycles.
STAT Trials Pulse, a new platform developed in partnership with AppliedXL, mines these hidden signals in public data to anticipate roadblocks in clinical trials. The predictive algorithms powering the platform identify irregularities in clinical trials data preceding timeline delays, disruptions, and other red flag signals before they become news. These early indications allow professionals to anticipate, understand, and address potential disruptions to drug development before they become public knowledge.
Our latest e-book highlights the power of AI for real-time clinical intelligence in biotech and how it helps life sciences professionals to strategize and make moves ahead of the news cycle.
DOWNLOAD E-BOOK
More STAT E-Books
Challenges for today's transformative gene and cell therapies
Gene editing and cell therapy have revolutionized medicine and given patients with serious or life-threatening illnesses an increased chance for remission. But limitations pose significant challenges to the widespread use of these potentially life saving treatments. Download this e-book to read more about the hurdles these treatments still face.
No comments